home / stock / khtrf / khtrf quote
Last: | $4.19 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $4.19 |
High: | $0 |
Low: | $0 |
Volume: | 3,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.19 | $0 | $4.19 | $0 | $0 | 3,000 | 04-25-2024 |
$4.19 | $0 | $4.19 | $0 | $0 | 2,600 | 04-24-2024 |
$4.19 | $0 | $4.19 | $0 | $0 | 2,200 | 04-23-2024 |
$4.19 | $0 | $4.19 | $0 | $0 | 4,200 | 04-22-2024 |
$4.19 | $4.19 | $4.19 | $4.19 | $4.19 | 2,000 | 04-19-2024 |
$4.29 | $4.29 | $4.29 | $4.29 | $4.29 | 4,276 | 04-18-2024 |
$4.27 | $4.27 | $4.27 | $4.27 | $4.27 | 2,800 | 04-17-2024 |
$4.19 | $0 | $4.19 | $0 | $0 | 2,400 | 04-16-2024 |
$4.19 | $0 | $4.19 | $0 | $0 | 2,000 | 04-15-2024 |
$4.19 | $4.19 | $4.19 | $4.19 | $4.19 | 6,000 | 04-12-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 1,800 | 04-11-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 2,700 | 04-10-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 14,300 | 04-09-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 1,900 | 04-08-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 2,175 | 04-05-2024 |
$3.94 | $0 | $3.94 | $0 | $0 | 2,000 | 04-04-2024 |
$3.94 | $3.91 | $3.94 | $3.94 | $3.91 | 2,800 | 04-03-2024 |
$3.961 | $3.961 | $3.961 | $3.961 | $3.961 | 5,100 | 04-02-2024 |
$3.8783 | $3.8783 | $3.8783 | $3.8783 | $3.8783 | 1,800 | 04-01-2024 |
$3.92 | $4.041 | $3.92 | $4.041 | $3.92 | 11,411 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Knight Therapeutics Inc Company Name:
KHTRF Stock Symbol:
OTCMKTS Market:
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the ...
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list. This an...
MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2023. All currency ...